Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs9769403 | chr7:105163091 | G/A | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs9791310 | chr6:147391341 | G/A | 2.13E-8 | 175 | 25.67 | 19.72 | 8.67 | KM Plot |
PCPG | rs9808363 | chr2:114407835 | A/C | 0.000352 | 174 | 25.28 | 27.27 | 8.9 | KM Plot |
PCPG | rs9833952 | chr3:136662603 | G/A | 0.000469 | 177 | 22.15 | 27.33 | 23.03 | KM Plot |
PCPG | rs9841643 | chr3:122261307 | G/A | 7.7E-11 | 175 | 24.85 | 25.97 | 5.8 | KM Plot |
PCPG | rs9841726 | chr3:53515794 | T/C | 0.00026 | 170 | 25.67 | 20.2 | 31.43 | KM Plot |
PCPG | rs9841897 | chr3:122282569 | T/C | 9.44E-5 | 174 | 25 | 28.93 | 10.3 | KM Plot |
PCPG | rs9842425 | chr3:80513710 | T/C | 8.22E-5 | 174 | 19.87 | 24.03 | 25.67 | KM Plot |
PCPG | rs9851562 | chr3:195731741 | G/A | 1.24E-5 | 177 | 24.52 | 31.47 | 13.38 | KM Plot |
PCPG | rs9859051 | chr3:80396096 | G/A | 5.33E-7 | 175 | 25.77 | 23.48 | 19.87 | KM Plot |
PCPG | rs9861150 | chr3:136183320 | G/T | 0.000157 | 170 | 24.1 | 25.87 | 26.27 | KM Plot |
PCPG | rs9861517 | chr3:122261379 | T/C | 7.7E-11 | 175 | 24.85 | 25.97 | 5.8 | KM Plot |
PCPG | rs9865208 | chr3:147819531 | T/A | 0.000219 | 170 | 25.77 | 25.92 | 19.15 | KM Plot |
PCPG | rs9867435 | chr3:80407418 | G/A | 6.03E-7 | 174 | 25.67 | 23.48 | 19.87 | KM Plot |
PCPG | rs9874186 | chr3:80581713 | A/C | 5.68E-5 | 172 | 25.17 | 23.53 | 27.4 | KM Plot |